ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Pascal Soriot, 50, will take over in 2010 as chief operating officer of Roche’s pharma division, which has been led by CEO William M. Burns. Soriot has served as CEO of Genentech since Roche’s March acquisition of the biotech firm. He will be succeeded in that role by Ian Clark, 49, currently head of global product strategy for Roche’s pharmaceutical business. In other management changes, Daniel O’Day, 45, has been appointed COO of Roche’s diagnostics division, succeeding diagnostics CEO Jürgen Schwiezer, who is retiring. On the R&D side, Jean-Jacques Garaud, 54, will assume responsibility for Roche Pharma Research & Early Development.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X